Maxims applied: How Pfizer's Maxim Violation with Nektar to develop and bring to market an inhaled insulin product called Exubera

  2069      Nov 30, -0001
Itís one of the most basic of maxims: that all marketing is based on needs, wants, features, and benefits. Where most go wrong, and Pfizer did so costly in this case study, is that they focus on features and wants because . . .
About weVISION: weQuest's are written by G Dan Hutcheson, his career spans more than thirty years, in which he became a well-known as a visionary for helping companies make businesses out of technology. This includes hundreds of successful programs involving product development, positioning, and launch in Semiconductor, Technology, Medicine, Energy, Business, High Tech, Enviorntment, Electronics, healthcare and Business devisions.

You may like this also:

Yalin Firinci
19 August, 2019

Regulatory Science for R&D Promotion

At present, the nationís policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

18 August, 2019
16 August, 2019

Stewards of High-Value Imaging

This project helped strengthen the relationship between the radiologists and ED physicians and set the stage for increased collaboration over time.

15 August, 2019
Kosuke Lijima
14 August, 2019
13 August, 2019
13 August, 2019

Antimicrobial Resistance Strategy and Use

Determined by the quality of the antimicrobial and by the distribution, prescription, and administration of veterinary medicinal products containing antimicrobial agents.

Matthew Stone
13 August, 2019

Recent weVISIONs

Tom Caulfield on what's next at GLOBALFOUNDRIES
22 July, 2019
IBM Research AI Hardware Center ... with Mukesh Khare of IBM
Mukesh V. KhareIBM
20 May, 2019